newsfilter
← Latest News
ClinicalTrials.gov·

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors - NCT05311618

Number of Patients with Dose-limiting Toxicities, Number of Patients with Adverse Events, Number of Patients with Clinically Significant Laboratory Abnormalities, (and 12 more...)